Core Insights - Intelligent Bio Solutions Inc. reported a 50% increase in new customer accounts during the fiscal first quarter, totaling over 480 active accounts, indicating strong customer expansion and revenue momentum [1][3][4] Company Performance - The company added 33 new customer accounts in the fiscal first quarter ended September 30, 2025, compared to the same period last year [1] - Approximately 91% of new accounts were first-time adopters of the drug screening solution, while 9% were expansions within existing customer organizations [3] - The company aims to convert current momentum into sustained revenue growth and long-term value [3] Market Trends - The global drug screening market is projected to reach USD 17.1 billion by 2029, growing at a CAGR of 15%, driven by increasing regulatory focus on workplace safety and demand for non-invasive testing solutions [4] - Adoption of the Intelligent Fingerprinting Drug Screening System is broadening across various industries, reflecting its scalability and alignment with modern compliance standards [5] Sector Growth - Strongest growth in customer acquisition was noted in sectors such as maritime, transportation and logistics, electrical and electronic manufacturing, construction, and government administration [2] - Government administration is a newly entered sector, highlighting the expanding applicability of the company's solutions [2]

Core Insights - Intelligent Bio Solutions Inc. has launched localized websites in Arabic, Italian, and Spanish to enhance its global growth and international sales efforts, targeting regions with a combined population of over 1.4 billion people [1][2] Group 1: Localization Strategy - The new websites are part of a broader localization strategy aimed at operational readiness and market alignment to capture revenue opportunities in Europe, the Middle East, and Latin America [2] - The initiative is described as a commercial growth engine rather than just a translation project, focusing on building scalable access to high-potential markets [3] Group 2: Market Opportunities - The drug screening market in Latin America is projected to reach USD 1.1 billion by 2030, with Spanish as the official language in 20 countries [4] - The Gulf Cooperation Council (GCC) countries are enhancing workplace safety standards, increasing demand for compliant screening solutions in the Middle East [4] Group 3: Sales and Distribution - The new websites are expected to strengthen inbound demand and accelerate conversion across distribution and sales channels by removing language barriers [5] - The company has over 400 active accounts in 19 countries, indicating a strong presence in various industries including construction, manufacturing, transport, and logistics [6]

Core Viewpoint - Intelligent Bio Solutions Inc. is expanding its Intelligent Fingerprinting Drug Screening System to include Latin American Spanish, addressing the growing demand in Spanish-speaking markets and enhancing accessibility for over 4 billion potential users worldwide [1][4]. Company Developments - The integration of Latin American Spanish into the System is part of a major multilingual upgrade aimed at improving usability across diverse international settings [1][4]. - The Company has over 400 accounts across 19 countries and is preparing to enter the multi-billion-dollar U.S. market following its FDA 510(k) submission in December 2024 [4]. Market Insights - The Latin American drug screening market is projected to reach USD 1.1 billion by 2030, driven by increasing public safety initiatives and workplace compliance programs [3]. - Spain's drug testing market is expected to reach USD 368.4 million by 2030, reflecting similar trends in regulation and adoption [3]. Strategic Growth - The enhancement of the System to support Latin American Spanish strengthens the Company's position in Spanish-speaking markets and aligns with its strategic growth plans [2][3]. - The multilingual capabilities of the System are seen as a key differentiator in the market, providing local language support that many competitors do not offer [3].